English | Español
Press release submission | Nov 5, 2021

Spinal Cord Stimulator (SCS) Changes Patients' Lives Patient Pain Relief with Treatment

Press release submission | Nov 4, 2021

US Food and Drug Administration Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure

Press release submission | Nov 4, 2021

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

Press release submission | Nov 4, 2021

Remote Patient Monitoring Platform 100Plus Powered by Artificial Intelligence Health Assistant Ava Leads to Improved Health Metrics for Senior Adult Patients

Press release submission | Oct 31, 2021

HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients

Press release submission | Oct 30, 2021

Akebia Announces Otsuka's Submission of Initial Marketing Authorization Application to the European Medicines Agency for Vadadustat for the Treatment of Patients with Anemia due to Chronic Kidney Disease

Press release submission | Oct 29, 2021

Banty's Dr. Richard Tytus Explains How to Have Successful Virtual Medicine Appointments with Patients

Press release submission | Oct 29, 2021

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program